logo
Plus   Neg
Share
Email

Deere & Co Q3 Profit Misses Estimates; Cuts 2019 Profit View - Quick Facts

Deere & Co. (DE) reported that its net income for the third quarter ended July 28, 2019 declined to $899 million or $2.81 per share, from $910 million or $2.78 per share last year.

Adjusted net income was $2.71 per share compared to $2.59 in the previous year. Analysts polled by Thomson Reuters expected the company to report earnings of $2.85 per share for the quarter. Analysts' estimates typically exclude special items.

In Friday pre-market trade, DE is trading at $139.00, down $4.71 or 3.28 percent.

Worldwide net sales and revenues for the quarter decreased 3 percent to $10.04 billion from the previous year. Analysts expected revenues of $9.39 billion.

The company now expects net income attributable to the company for fiscal year 2019 to be about $3.2 billion, compared to the prior outlook of $3.3 billion.

The company still expects net sales and revenues to increase about 5 percent for fiscal 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT